Although several clinically useful synthetic penicillins have been prepared by the acylation of 6-amino-penicillanic acid, chemical modification of the natural penicillins has been unproductive. Several carboxyl derivatives which were microbiologically inactive or possessed only a low order of activity have been prepared (8, 10) . It has been generally assumed that they are inactive because they lack the electron-negative carboxyl group necessary for attachment to some electron-deficient active site.
A number of semisynthetic penicillins have been developed (methicillin, oxacillin, etc.) which are markedly resistant to destruction by ,3-lactamase. Many investigators think that the bulky acyl group adjacent to the ,3-lactam ring present in these derivatives contributes to this stability. However, penicillin amide derivatives are also resistant to f3-lactamase destruction (2, 3) . Such derivatives may owe their resistance to the fact that, lacking the electron-negative carboxyl group, they are incapable of forming a substrate-enzyme complex. On the other hand, if these penicillin amides can form stable enzyme complexes, they might act as competitive inhibitors and thus prevent the destruction of penicillin G when the two compounds are present simultaneously.
The original reports (3, 8) would be uncovered against one or more penicillin G-resistant organisms.
It occurred to us that a penicillin hydroxamic acid might be a uniquely active compound, impervious to f3-lactamase by virtue of the amide linkage, yet active because of the acidic character of the group. We found that the hydroxamic acids of several penicillins have been disclosed in the patent literature (4, 5) . In our experiments, the synthetic methods given in the patents were not productive, so an alternate synthetic method for penicillin G hydroxamic acid was developed. An intermediate in our synthesis was O-benzylhydroxamide of penicillin G (compound 5) from which the hydroxamic acid was obtained by catalytic hydrogenation (Fig. 1) .
A well-supported mechanism of penicillin action (9, 11) (gly-gly-glyOH) tive. Activity could be a function of the presence of an extracellular amidase which converts the amide derivatives back to penicillin G. This possibility is being investigated. All derivatives which possessed significant activity against the Copenhagen strain of Staphylococcus aureus were retested with a penicillin G-resistant strain (4180) of S. aureus (Table 1) . In every case (except compounds 5, 6 , and 15), there was significantly less activity against the resistant strain, although compounds 5, 6 , 15, and 17 were more active than penicillin G. The O-benzyl-hydroxamide of penicillin V and several other 0-substituted hydroxamides were highly active against two resistant strains of S. aureus (4) . Compounds 5 (the O-benzyl derivative) and 6 (penicillin G hydroxamic acid) were then assayed against an additional group of seven penicillin G-resistant clinical isolates of S. aureus (Table 2 ). It is apparent that compound 5 has a greater activity against five of these strains than either oxacillin or methicillin. The resistance of this compound to f-lactamase was also determined by the manometric method of Henry and Housewright (7) . In this assay, its susceptibility to fl-lactamase approximated that of cloxacillin.
Contrary to expectations, penicillin G hydroxamic acid (compound 6) was a disappointing compound and was consistently less active than the neutral O-benzylhydroxamide derivative.
The derivatives of penicillin G in which one or more amino acids are linked to the molecule through the carboxyl group (compounds 7 to 10, 13, and 19) were not outstanding in their antibacterial activity, although they were more active against M. roseus, S. pyogenes, Sarcina lutea, and C. diphtheriae than those amide derivatives (compounds 2 to 4) which did not possess a terminal carboxyl group. Cephalothinamide (compound 15) appears to be less active than cephalothin (compound 14) per se (Table 1) . (Benzyloxy)carbonylampicillin (compound 20) retained full activity against gram-positive bacteria but was much less active against an ampicillin-sensitive strain of E. coli than ampicillin (compound 16).
The stability of several of the penicillin amides toward f-lactamase was confirmed. Attempts to prevent inactivation of penicillin G by competition with penicillin G amide were unsuccessful. Combinations of penicillin G and the amide in various ratios were incubated with f3-lactamase. There was a suggestion of penicillin G protection by the amide, but no significant differences were found. Similarly, eight different penicillinaseproducing strains of S. aureus were found to be equally refractory (MIC values all greater than 100 mg/ml) to penicillin G, penicillin G amide, and various combinations of the two agents. In view of these results, it is unlikely that amide derivatives can be expected to protect penicillin G against /3-lactamase by a competitive inhibition mechanism. It appears that the amide is able to form only a loose enzyme complex, if at all.
Of the 17 compounds synthesized, penicillin G benzyl-hydroxamide (compound 5) demonstrated the greatest degree of antistaphylococcal activity ( Table 2 ). Since the magnitude of the in vivo activity of this compound was unknown, it was of interest to determine its activity in mice infected with streptococci. A low order of chemotherapeutic effectiveness was obtained with this derivative (Fig. 5) . The poor in vivo activity of the compound may be attributable to its high degree of binding to serum proteins (Table 3) .
